23.09.13
New MHRA chief executive takes up his role
The new chief executive of the Medicines and Healthcare Products Regulatory Agency (MHRA) has started work today.
Dr Ian Hudson, who had been the MHRA’s director of licensing for 12 years, has replaced Professor Sir Kent Woods, who has stepped down after ten years with the Agency.
Dr Hudson joined the MHRA after a career as a physician specialising in paediatrics, as well as time spent in the pharmaceutical industry working in clinical research and drug development.
MHRA chairman, Sir Gordon Duff said: “Ian has excellent, broad experience across all aspects of medicines regulation and is ideally placed to lead our agency, which is unique in bringing together medicines and medical devices regulation together with world-class research facilities and expertise.”
Dr Hudson said: “The Agency plays a critical role in ensuring that medicines and medical devices help people and are acceptably safe; we support research and development; and protect and promote the health of millions of people through our activities.
“Sir Kent has led the Agency very effectively and has developed it into one of the leading medicines and medical devices regulators in the world. I am proud to have been selected to succeed him.”
Sir Kent will continue as chair of the Management Board of the European Medicines Agency.
The Agency consists of three centres: the Clinical Practice Research Datalink (CPRD), the National Institute for Biological Standards and Control (NIBSC) and the MHRA itself.
Tell us what you think – have your say below or email [email protected]